Free tool
Drug Trial Radar: Gastroenterology and liver
Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
3
Not yet recruiting, industry sponsors, Gastroenterology and liver, Phase 1
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed197
3 trials
Showing 1 to 3, recently updated first.
- DDI Study of ECC0509 With Metformin, Midazolam, and CaffeineNot yet recruiting
EccogeneIndustry
NCT07873229 · 40 participants (planned) · Start Nov 2026 · Primary completion Mar 2027
Drug: ECC0509; Metformin and 2 more · For: Steatohepatitis, Nonalcoholic; Osteo Arthritis
Sites: Melbourne, Australia
Korea United Pharm. Inc.Industry
NCT07727629 · 60 participants (planned) · Start Jul 2026 · Primary completion Aug 2026
Drug: UI059; UIC202201 · For: Gastro Esophageal Reflux Disorder
Sites: Cheongju-si, South Korea
- A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120ANot yet recruiting
Addpharma Inc.Industry
NCT06916130 · 48 participants (planned) · Start Apr 21, 2025 · Primary completion Sep 1, 2025
Drug: AD-120A; AD-120 · For: Gastroesophageal Reflux Disease (GERD)
Sites: Seoul, South Korea
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.